Furosemide Tablets

Award NoticeAwarded

This federal contract opportunity has been awarded to on December 8, 2021.

Award Information

DEPT OF DEFENSE awarded this contract to for $16,701,924 on December 8, 2021, as part of federal procurement initiatives.

This award is part of federal acquisition procurement activities.

Award Number
SPE2D222D0140
Award Amount
$16,701,924
Award Date
December 8, 2021

Key Takeaways

  • No response deadline specified - contact the agency for details
  • Full and open competition - all businesses eligible to bid
  • Work to be performed in PHILADELPHIA, PA
  • Industry: Pharmaceutical Preparation Manufacturing

Contract Details

Notice ID
SPE2D221R0110
Opportunity Type
Award Notice
Sub-Agency
DEFENSE LOGISTICS AGENCY
Office
DLA TROOP SUPPORT
Posted Date
Tuesday, November 25, 2025
Response Deadline
Not specified
PSC Code
6505
Set-Aside
Full & Open Competition
Place of Performance
PHILADELPHIA, PA, 19111
Status
Active

Description

SPE2D2-22-D-0140 P00008 to exercise Option Year 4 effective December 08, 2025 through December 07, 2026. SPE2D2-22-D-0140 P00007 is modified in accordance with DoD Class Deviation 2025-O0003. SPE2D2-22-D-0140 P00006 to exercise Option Year 3 effective December 08, 2024 through December 07, 2025. SPE2D2-22-D-0140 P00005 is issued to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders into subject solicitation. SPE2D2-22-D-0140 P00004 to exercise Option Year 2 effective December 08, 2023 through December 07, 2024. SPE2D2-22-D-0140 P00003 to incorporate Drug Supply Chain Act (DSCA) language into solicitation for subject contract. SPE2D2-22-D-0140 P00002 to Incorporate FAR 52.204-27 Prohibituion on a Bytedance Covered Application (June 2023) into contract. Invocation

Why This Opportunity Matters

The Department of DEFENSE is seeking responses for pharmaceutical preparation manufacturing in PHILADELPHIA, PA.